As of August 28, 2026, Dermata Therapeutics, Inc. (DRMA) has a DilutionWatch DilutionScore of 87/100, rated CRITICAL dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. Dermata Therapeutics, Inc. has a market capitalization of $5.23M, 4.02M shares outstanding, 2 institutional holders tracked. Stored dilution-related fields include 5.42M outstanding warrants.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
⛈️
Warning
High probability of dilution event
model est. 56%
📜 Warrant Exercise
model 60%
• Massive warrant overhang: 135% of shares outstanding
• Warrant risk score very high (90/100)
🔁 Convertible Conversion
model 60%
• Major convertible overhang: 49% potential dilution
• Convertible risk score very high (85/100)
🔄 Reverse Split
model est. 40%
• 50-day avg $1.28 approaching $1 threshold
• 6 months cash with weak price
Market Data
Market Cap$5.23M
Shares Outstanding4.02M
Float3.17M
Cash$4.41M
DebtN/A
Short InterestN/A
Institutional Holdings
2 institutional holders · 89.9K shares
#1
MORGAN STANLEY
89.8K shares
#2
BARCLAYS PLC
180 shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest50.8K
Days to Cover1.0
% of Float1.6%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL WARRANT
2026-06-30
xbrl
XBRL CONVERTIBLE
2022-12-31
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual DRMA Dilution Snapshot
Dermata Therapeutics, Inc. (DRMA) has a DilutionScore of 87/100, rated Critical dilution risk. Score date: August 28, 2026.
- Stored outstanding warrants: 5.4M.
- Recent SEC activity tracked for DRMA: xbrl on 2026-06-30; xbrl on 2022-12-31.
- Score coverage note: Debt is unavailable or zero in the market-data feed while convertible risk is high; convertible overhang is shown separately and is not reconciled to the Debt field.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track DRMA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking DRMA — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
Score Coverage Note
- Debt is unavailable or zero in the market-data feed while convertible risk is high; convertible overhang is shown separately and is not reconciled to the Debt field.
More Research for DRMA
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.